Redefining Laboratory Coagulation Roche Becomes A New Player

9m ago
651.29 KB
12 Pages
Last View : 6d ago
Last Download : n/a
Upload by : Averie Goad

cobas t 411 coagulation analyzerDriven by commitment, powered by Roche

Redefining laboratory coagulationRoche becomes a new playerRoche began its journey in the area of hemostasis withthe CoaguChek meter, which today is the most widelyused point-of-care device for warfarin monitoring inthe world. For many years, Roche has forged strongalliances with external partners in the areaof central coagulation laboratory market and has a market leading position in many countries. Today,Roche is developing its own comprehensive portfoliofor the central coagulation laboratory that will beavailable globally. The portfolio will provideoutstanding productivity while reducing complexity byaddressing current and future testing requirementsacross a broad range of customer segments.Consistent with current Roche portfolios and drivenby commitment to deliver customer focused, qualityoriented and cost effective products, Roche will enterinto a new era of testing solutions for coagulationlaboratories.

cobas t 411 coagulation analyzerProviding safety, efficiency and productivityThe cobas t 411 coagulation analyzer is the newestmember of the Roche diagnostic portfolio and beginsa new era for Roche in the world of coagulation.Best-in-class reagent, sample and cuvette storagecapacity means the analyzer is not only easy to usebut also requires minimal interaction during daily use.Covering the diverse needs of today’s coagulation labs,the cobas t 411 coagulation analyzer is ideally suitedfor maximum flexibility and efficiency. The cobas t 411coagulation analyzer is designed for the low to mediumthroughput laboratory.The cobas t 411 analyzer is designed with a uniqueset of enhanced safety features to ensure robust andhigh quality patient results, every time.A host of other innovative features includeautomated, multi-vendor cap-piercing, maximizedreagent utilization and integrated barcode scanningfor samples and reagents.

cobas t 411 coagulation analyzerDynamic workflow, safety and reliability17352641Cuvette compartment 240 cuvettes 4 channel cuvette racks Continuous loading2Sample area 100 samples on-board Dedicated STAT port Continuous loading via 5 position racks3Cap-piercing Multi-vendor compatibility4Software Linux-based operating system Comprehensive QC program includingLevey-Jennings Full result traceability function User-definable protocols5Reagent compartment Up to 70 vials on-board capacity Continuous rack-based loading withLED status indication Extended routine menu including: PT,APTT, FIB, TT, AT and DD6Reading station Slide in reading position SW guided reagent management7Measurement position 140 tests/hr (PT) 100 tests/hr (mixed mode) 4 position LED measurement system w ith405 nm and 620 nm Unique opto-mechanical measuringprinciple Clotting, chromogenic, immunoturbidimetric assays

cobas coagulation analyzersDriven by commitment, powered by RocheResponsive roadmapDesigned with and for global customers,the cobas t 411 coagulation analyzeris the first member in Roche’s new seriesof coagulation analyzers.Quality and reliabilityProven premium Roche quality meansthe cobas t 411 coagulation analyzer isreliable and robust with minimum downtime.Combined with an established,experienced global support network Rocheensures maximum up-time.Workflow dynamicsFeaturing continuous loading of reagents,samples and cuvettes, the cobas t 411coagulation a nalyzer ensures m aximumproductivity for demanding laboratoryworkloads.Premium safetyAutomatic cap piercing for all tube typescombined with positive s ample identificationwith automatic, on-board barcode scanningensure patient and operator safety are notcompromised.

Maximizing productivity and efficiency, the cobas t 411coagulation analyzer ensures optimization of workflowprocesses in the coagulation labDriven by commitment, powered by RochePassion for dynamic workflowWith flexible, continuous loading of samples, reagentsand cuvettes at any time in combination withlarge onboard storage capacity, walk-away time ismaximized and hands-on time minimized.A dedicated port is always available for STAT testing.Multi-vendor compatible, automated cap piercingensures maximum flexibility for efficient workflow inthe busy laboratory.

Patient and operator safety are paramountDriven by commitment, powered by RochePassion for premium safetyAutomated cap-piercing and positive samplemanagement via the integrated automatic barcodescanner means patient and operator safety are nevercompromised. Patient safety is further ensured viathe unique opto-mechanical detection system and‘measurement readiness’ check.Patient results are fully traceable utilizing a featurethat allows the user to check which calibrator, controland reagent lots were used to obtain the result.

Serviceability by design, the cobas t 411 coagulationanalyzer from Roche is built to, and s upported by,exacting quality standardsDriven by commitment, powered by RochePassion for quality and reliabilityDesigned for superior serviceability with a dailymaintenance time of just 5 minutes, premiumreliability is achieved.Furthermore, only one preventative maintenanceper year is required. With Roche’s extensive globalsupport network and its established experience incoagulation, maximum up-time and cost efficiencyare assured.Reliable hardware ensures continuous operation.All of this in combination means better costeffectiveness for the laboratory.

The cobas t 411 is the newest member of the Rochefamily series of Coagulation analyzersDriven by commitment, powered by RocheResponsive roadmapRoche has taken a proactive, responsive approach tothe design of the new coagulation portfolio. Designedbased on global customer input, Roche’s pipeline forthe future in hemostasis is well defined.The cobas t 411 coagulation analyzer is the powerfulfirst member of the new coagulation series.Roche’s next generation platforms will offer trulyground-breaking, innovative automation features andwill set new standards in lab coagulation.

Passion for hemostasisHelping to improve patient care and diagnostic efficiencyConsistent with a world-wide presence and commitment in offeringtotal testing solutions, Roche’s new coagulation product portfoliowill be available globally. Roche’s distinctiveness and uniquecapabilities, combined with a broad array of technologies, enableRoche to further strengthen its leadership position and delivervalue to its customers and patients worldwide.Self- & professional monitoringMolecular and plateletfunction testingcobas IT solutionsLightCycler InstrumentMultiplate analyzerCoaguChek XS systemCoaguChek XS Plus systemCoaguChek XS Pro systemLaboratory automationcobas p 512 and cobas p 612 pre-analytical system (former RSD pro)cobas 8100 automated workflow seriescobas p 501 and cobas p 701 post-analytical unitRoutine and specialty testingcobas t 411 coagulation analyzercobas t 511 coagulation analyzercobas t 711 coagulation analyzer

COBAS, COBAS P, COBAS T, LIFE NEEDS ANSWERS,COAGUCHEK, MODULAR PRE-ANALYTICS EVO andMULTIPLATE are trademarks of Roche.All other trademarks are the property of their respectiveowners. 2015 RocheRoche Diagnostics International LtdCH-6343

the cobas t 411 coagulation analyzer is the first member in Roche’s new series of coagulation analyzers. Quality and reliability Proven premium Roche quality means the cobas t 411 coagulation analyzer is reliable and robust with minimum downtime. Combined with an established, experienced global support network Roche ensures maximum up-time.

Related Documents:

16390 16400 16410 16420 16430 16440 FBI A1 (L15997) Roche (F15975) HV1 16093 16126 16129 HVI C-stretch Roche IA Roche ID Roche IE Roche IC HV1 FBI B1 (H16391) Roche (R16418) Hypervariable Region I 16024-16365 342 bp examined SSO Probes 16093 16126 16129

Left: Clinical chemistry analyzer Roche ELECSYS 2010 und Roche Hitachi 917. Right: Clinical chemistry analyzer Roche Hitachi 717. Central laboratory - . Right: Coagulation analyzer Sigma AMAX (special analyzes). Clotting laboratory -

Michael Crowley, Head of Business Development Roche Research & Early Development, Pharma Partnering Roche Company Presentation. 2 The Roche Group: an innovation-driven company Why we make a good partner What we are looking for from you. 3 What we are looking The Roche Group: an for from you

Roche und der Geschäftsleitung der Roche in Verhandlungen mit dem AVR erarbeitet worden. und gelten für folgende Roche-Gesellschaften, inkl. ihrer Zweigniederlassungen in der Schweiz: . – Individuelle Leistungen und Beiträge zum Erfolg von Roche werden vom Arbeitgeb

Investor Update F. Hoffmann-La Roche Ltd 4070 Basel Switzerland Investor Relations email: [email protected] Tel. 41 61 68-88880 Fax 41 61 69-10014 1/11 Basel, 30 January 2020 Roche reports very strong results in 2019 1Group sales increase 9% at constant exchange rates and 8% in Swiss francs, driven by new products,

1 Coagulation and Rapid Mixing Coagulation is the process by which particles become destabilized and begin to clump together. Coagulation

The cobas t 711 coagulation analyser can also be connected with the cobas 8100 and the cobas connection modules. Both analysers can be used in rand om-access or batch modes, and offer true STAT capabilities, with dedica ted slots for urgen t samples. cobas t 511 coagulation analyzer

cobas t 411 coagulation analyzer 5.478 3.261 1 cobas t 511 coagulation analyzer 8.757 4.413 1 cobas t 711 coagulation analyzer 11.855 5.973 1 MultiplateT analyzer 1.310 – – – Urindiagnostik cobas u 601 urine analyzer 4.989 – – – cobas

Source of Saturn’s Rings The moon’s own gravity tends to hold it together. Tidal forces from planet tend to pull it apart The “Roche Limit” is the critical distance where the two balance Saturn’s moons are (mostly) outside of Roche Limit Saturn’s rings are (mostly) inside the Roche limit. Roche Limit (2.4 Saturn .

The court also received evidence from Ms Maria Roche. Ms Roche is the Tumut Cluster Manager for Murrumbidgee Local Health District. As at 1 January 2016, Ms Roche was the Acting Rural Group Manager for the Riverina Group, which included Tumut Health Service. She had been in that role since 2013. Ms Roche gave oral evidence but also provided four

COAGULATION TESTING ON ROTEM The basic principles and technical aspects of TEG and ROTEM have been reviewed elsewhere.14,38-40 In this article, the practical applications of ROTEM are described because this system currently offers comprehensive tests of coagulation. For standard ROTEM measurements, a citrated whole-blood sam-

and adding ozone and irradiating with ultraviolet light. 1.2.2 Coagulation. In wastewater treatment operations, the processes of coagulation and flocculation are employed to separate suspended solids from water. Although the terms coagulation and floccu

Performance of 6 routine coagulation assays on the new Roche Cobas t711 analyzer Marlies Oostendorpa,b, Roefke L. Noormana, J. Dinant Nij

1) basic coagulation terms, 2) basic requirements for changing lot numbers, 3) some examples of interfering substances, 4) common problems in the collection and processing of coagulation testing samples, and 5) miscellaneous information. Please Note: For single-use devices (e.g. Roche Diag

coagulation analyzer (Roche Diagnostics, Mannheim, Germany), while the remaining blood was mixed into a 3.2% sodium citrate tube and then centrifuged at 3000 g for 15 min. The plasma was harvested and stored at 20 C before testing using an ACA (Sysme

Country where analyzer designed/Manufactured Germany/Germany Germany/Germany France/France . (Beckman Coulter, Bayer LabCell, Roche MPA) . Coagulation Analyzers. Tabulation does not represen

says Jill Downey, Roche Diagnostics’ Coagu-Chek product marketing manager, profes-sional diagnostics—physician office lab. Roche designed its CoaguChek XS, XS Pro, and XS Plus coagulation meters to use the same test strips. The CoaguChek XS Plus meter received a CLIA wai

Multiplate Analyzer (Roche, F. Hoffmann-La Roche Ltd., Switzerland) is a point-of-care (POC) device that allows, in a very short time, the bedside assessment of the platelet activity. In patients undergoing cardiac surgery, coagulation diagnosis methods, such as throm-boelastometry a

Both Roche and Abbott have added or will soon add capabilities to their existing analyzers. Roche plans to launch a new PT-S test strip for use with the company's Co-aguChek S analyzer. The new strip will feature simplified liquid con-trols, insensitivity to heparin or low-molecular-weight

2 API R. ECOMMENDED. P. RACTICE. 500. 1.2.4. Section 9 is applicable to locations in which flammable petroleum gases and vapors and volatile flammable liquids are processed, stored, loaded, unloaded, or otherwise handled in petroleum refineries. 1.2.5 . Section 10 is applicable to location s surrounding oil and gas drilling and workover rigs and production facilities on land and on marine .